Proposed sale of 64,540 common shares under registered plan (RYTM)
Rhea-AI Filing Summary
RYTM filing reports a proposed sale of 64,540 common shares on 03/04/2026 described as an exercise of options under a registered plan. The filing also records a sale of 35,460 common shares by Camille L. Bedrosian on 03/03/2026 for $3,209,778.92.
Positive
- None.
Negative
- None.
Insights
Form 144 notes a brokered resale following option exercise and a recent insider sale.
The entry lists 64,540 common shares to be sold on
Examples shown include a prior sale by Camille L. Bedrosian of 35,460 shares on
The notice follows standard resale procedures for restricted or control securities.
The excerpt lists Morgan Stanley Smith Barney LLC and identifies the transaction as involving the issuer and an exercise under a registered plan, verbatim. The broker line and plan descriptor align with routine resale mechanics.
Regulatory outcome depends on timing and transaction reporting; this filing documents intent rather than confirmed settlement.
FAQ
What does the RYTM Form 144 say was offered for sale?
Who recently sold RYTM shares according to the filing?
Was the RYTM sale related to option exercise?
Which broker-dealer appears in the RYTM Form 144?
Does the filing confirm settlement or proceeds recipient for the 64,540 shares?